IDEXX Laboratories Inc/ US45168D1046 /
| 2024-05-07 10:00:00 PM | Chg. +6.8100 | Volume | Bid1:28:10 AM | Ask1:28:10 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 483.6800USD | +1.43% | 368,074 Turnover: 87.37 mill. |
483.8800Bid Size: 200 | 504.0000Ask Size: 200 | 39.95 bill.USD | - | 47.56 |
Assets
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 281.2000 | 303.5870 | 333.0260 | 357.4220 | 379.0960 | ||||||
| Intangible Assets | 58.8000 | 65.1220 | 55.9090 | 46.1550 | 43.8460 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | 624.8130 | 653.3590 | 685.1200 | 741.4310 | ||||||
| Inventories | 133.4000 | 160.3420 | 188.8330 | 158.0340 | 164.3180 | ||||||
| Accounts Receivable | 158 | 152.3800 | 188.3180 | 204.4940 | 234.5970 | ||||||
| Cash and Cash Equivalents | 279.1000 | 322.5360 | 128.9940 | 154.9010 | 187.6750 | ||||||
| Current Assets | 652.7000 | 759.3980 | 821.6340 | 845.5840 | 971.9850 | ||||||
| Total Assets | 1,230.5000 | 1,384.2110 | 1,474.9930 | 1,530.7040 | 1,713.4160 | ||||||
Liabilities
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 29.9000 | 44.7430 | 52.6480 | 60.0570 | 66.9680 | ||||||
| Long-term debt | - | 350 | 597.0850 | 593.1100 | 606.0750 | ||||||
| Liabilities to Banks | 277 | 549 | 573 | 611 | 655 | ||||||
| Provisions | 148.9000 | 195.4000 | 205.5000 | 236.1000 | 253.4000 | ||||||
| Liabilities | 712.3000 | 1,266.6220 | 1,558.9880 | 1,638.9170 | 1,767.2580 | ||||||
| Share Capital | 10.1190 | 20.3900 | 10.2580 | 10.3340 | 10.4280 | ||||||
| Total Equity | 518.2000 | 117.5890 | -83.9950 | -108.2130 | -53.8420 | ||||||
| Minority Interests | .0300 | .0730 | .1300 | .1390 | .2640 | ||||||
| Total liabilities equity | 1,230.5000 | 1,384.2110 | 1,474.9930 | 1,530.7040 | 1,713.4160 | ||||||
Income Statement
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,377.1000 | 1,485.8070 | 1,601.8920 | 1,775.4230 | 1,969.0580 | ||||||
| Depreciation (total) | - | 58.8880 | 68.9560 | - | - | ||||||
| Operating Result | 266.8000 | 260.2550 | 299.9120 | 350.2390 | 413.0280 | ||||||
| Interest Income | -3.5000 | -13.7000 | -26.7710 | -28.3930 | -31.9710 | ||||||
| Income Before Taxes | 263.3000 | 246.5550 | 273.1410 | 321.8460 | 381.0570 | ||||||
| Income Taxes | 75.5000 | 64.6040 | 81.0060 | 99.7920 | 117.7880 | ||||||
| Minority Interests Profit | 0.0000 | .0450 | .0570 | .0090 | .1250 | ||||||
| Net Income | 187.8000 | 181.9060 | 192.0780 | 222.0450 | 263.1440 | ||||||
Per Share
Cash Flow
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 246 | 235.8460 | 216.3640 | 334.5710 | 373.2760 | ||||||
| Cash Flow from Investing Activities | -86.1000 | -80.4130 | -308.4060 | -90.7860 | -138.6880 | ||||||
| Cash Flow from Financing | -102.5000 | -103.4380 | -95.5520 | -217.8240 | -208.0160 | ||||||
| Decrease / Increase in Cash | 55.1000 | 43.4780 | -193.5420 | 25.9070 | 32.7740 | ||||||
| Employees | 5,700 | 6,400 | 6,800 | 7,365 | 7,600 | ||||||
